Skip to content
HowShorted

REGENXBIO Inc. short interest in 2024

In 2024, REGENXBIO Inc.'s disclosed short interest ran from 10.03% of shares outstanding on 12 Jan 2024 to 12.20% on 31 Dec 2024, a change of +2.17 percentage points. The year's high was 12.57% on 13 Dec 2024 and its low 8.13% on 15 May 2024, averaging 10.09% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.13 days on 30 Aug 2024. Full history: REGENXBIO Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for REGENXBIO Inc. in 2024

2024 in figures

Start of year
10.03% (12 Jan 2024)
End of year
12.20% (31 Dec 2024)
Change
+2.17 pp
High
12.57% (13 Dec 2024)
Low
8.13% (15 May 2024)
Average
10.09%
Highest days to cover
19.13 (30 Aug 2024)
SEC filings marked
8

Every report in 2024

REGENXBIO Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202410.03%5.82
31 Jan 20249.43%8.22
15 Feb 20249.49%4.90
29 Feb 20248.71%4.9810-K filed, results (8-K)
15 Mar 20249.43%3.19
28 Mar 20248.97%7.81
15 Apr 20249.24%8.76
30 Apr 20249.69%10.20
15 May 20248.13%10.5210-Q filed, results (8-K)
31 May 20248.76%11.13
14 Jun 20249.26%9.41
28 Jun 20248.77%4.15
15 Jul 20249.77%8.65
31 Jul 202410.51%10.24
15 Aug 202411.59%11.2610-Q filed, results (8-K)
30 Aug 202412.29%19.13
13 Sep 202412.55%14.54
30 Sep 202410.74%7.87
15 Oct 202410.09%9.55
31 Oct 20249.91%10.79
15 Nov 20249.31%5.5810-Q filed, results (8-K)
29 Nov 202410.62%5.01
13 Dec 202412.57%4.27
31 Dec 202412.20%2.81

See also: REGENXBIO Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.